MIF and pachyonychia congenita: Interestingly, in the non-cancer new-onset T2DM group, the serum MIF levels of female seemed to be higher than that of male (p = 0.051), but there was no difference in serum levels of MIF between male and female patients with new-onset DM PC (p = 0.362).